Crossmark

Human amnion-derived mesenchymal stem cells improve subclinical hypothyroidism by immunocompetence mediating apoptosis inhibition on thyroid cells in aged mice

Crossref DOI link: https://doi.org/10.1007/s00441-023-03822-1

Published Online: 2023-08-12

Published Print: 2023-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Chuyu

Rui, Qiang

Dong, Xiaohan

Ning, Song

Zhou, Jing

Wu, Huimin

Jiang, Chunyan

Cui, Yugui

Liu, Jiayin

Jiang, Jun https://orcid.org/0000-0001-6007-8940
Qin, Lianju
Funding

Funding for this research was provided by:

Innovative Research Group Project of the National Natural Science Foundation of China (81730041)

Innovative Research Group Project of the National Natural Science Foundation of China (81671447)
License Information

Text and Data Mining valid from 2023-08-12

Version of Record valid from 2023-08-12
More Information

Article History

Received: 30 November 2022

Accepted: 27 July 2023

First Online: 12 August 2023

Declarations

:

: All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC 1808004) of Nanjing Medical University in Jiangsu, China. Also, the collection and use of human amniotic membrane were conducted under the guidelines and with the approval of the First Affiliated Hospital with Nanjing Medical University (2012-SR-128).

: All patients provided written informed consent to the respective use of their tissues.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below